Literature DB >> 31079706

Y90 Radioembolization Dosimetry: Concepts for the Interventional Radiologist.

Beau Bosko Toskich1, David M Liu2.   

Abstract

Transarterial radioembolization (TARE) with beta particle emitting microspheres via Yttrium-90 decay has become a fundamental component of the contemporary Interventional Oncology practice. TARE continues to advance as a result of increased utilization, clinical study, technological improvements, and evolving applications. To maximize TARE safety and efficacy, a core understanding of dosimetry is essential. The intent of this overview is to provide the reader with a general survey of radiation physics and biology, device differentiation, patient selection, anatomic assessment, activity administration models, and procedural techniques involved with TARE dosimetry.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BSA; MIRD; Partition; Radiation Lobectomy; Radiation Segmentectomy; Radioembolization

Mesh:

Substances:

Year:  2019        PMID: 31079706     DOI: 10.1053/j.tvir.2019.02.011

Source DB:  PubMed          Journal:  Tech Vasc Interv Radiol        ISSN: 1557-9808


  5 in total

Review 1.  Yttrium-90 Radioembolization Dosimetry: What Trainees Need to Know.

Authors:  Alexander Villalobos; Mohamed M Soliman; Bill S Majdalany; David M Schuster; James Galt; Zachary L Bercu; Nima Kokabi
Journal:  Semin Intervent Radiol       Date:  2020-12-11       Impact factor: 1.513

Review 2.  Radioembolization for the Treatment of Hepatocellular Carcinoma: The Road to Personalized Dosimetry and Ablative Practice.

Authors:  Cynthia De la Garza-Ramos; Beau B Toskich
Journal:  Semin Intervent Radiol       Date:  2021-10-07       Impact factor: 1.780

3.  The use of neoadjuvant lobar radioembolization prior to major hepatic resection for malignancy results in a low rate of post hepatectomy liver failure.

Authors:  Altan Ahmed; John A Stauffer; Jordan D LeGout; Justin Burns; Kristopher Croome; Ricardo Paz-Fumagalli; Gregory Frey; Beau Toskich
Journal:  J Gastrointest Oncol       Date:  2021-04

Review 4.  Selective Internal Radiation Therapy with Yttrium-90 for Intrahepatic Cholangiocarcinoma: A Systematic Review on Post-Treatment Dosimetry and Concomitant Chemotherapy.

Authors:  Sedighe Hosseini Shabanan; Nariman Nezami; Mohamed E Abdelsalam; Rahul Anil Sheth; Bruno C Odisio; Armeen Mahvash; Peiman Habibollahi
Journal:  Curr Oncol       Date:  2022-05-24       Impact factor: 3.109

5.  Biochemical Safety of Ablative Yttrium-90 Radioembolization for Hepatocellular Carcinoma as a Function of Percent Liver Treated.

Authors:  Cynthia De la Garza-Ramos; Cameron J Overfield; S Ali Montazeri; Harris Liou; Ricardo Paz-Fumagalli; Gregory T Frey; J Mark McKinney; Charles A Ritchie; Zlatko Devcic; Andrew R Lewis; Denise M Harnois; Tushar Patel; Beau B Toskich
Journal:  J Hepatocell Carcinoma       Date:  2021-07-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.